Remembering Browning Marean

I was deeply saddened to learn of the passing of Browning Marean. Both Craig Ball and Chris Dale have written very eloquently about Browning. I encourage you to read both of their tributes.

Browning Marean was the senior statesman of eDiscovery. There are few people who had the grace and knowledge of Browning. The man had the voice of a classic radio broadcaster who made audiences stop and listen.

Browning_JudgePeck_LTWC2009

Browning set the gold standard when it came to giving a presentation. Whether he was moderating a panel discussion, delivering a keynote, or holding court with a judge, his style was unmatched.

To say Browning was an “early adopter” of technology is an understatement. Browning was the geek’s geek. The man loved technology. He joked he liked trying out a product before even the Beta test.

Browning had a natural gift to identify useful new technology. It was Browning who introduced me to Zoom.us, the product I now use for my audio and video podcasts. His one call to tell me about the product made a huge impact on work I do weekly.

I enjoyed my video calls with Browning. He usually greeted me with, “Joshua my good man, how are you?” I am going to greatly miss discussing the law, politics, and life with Browning.

I will never forget my adventures with Browning. He was a gentleman who cared about people, and a lawyer who set a high bar for the rest of us to follow.

Browning was a legend across the entire world of eDiscovery and he will be missed.

Browning_Iconect-April2012
Josh Gilliland is a California attorney who focuses his practice on eDiscovery. Josh is the co-creator of The Legal Geeks, which has made the ABA Journal Top Blawg 100 Blawg from 2013 to 2016 and was nominated for Best Podcast for the 2015 Geekie Awards. Josh has presented at legal conferences and comic book conventions across the United States. He also ties a mean bow tie.

5 comments

    1. Thank you. He touched a lot of lives. I am very glad you were able to visit him while he was undergoing treatment.

Comments are closed.